Intrinsic Value of S&P & Nasdaq Contact Us

Intersect ENT, Inc. XENT NASDAQ

NASDAQ Global Market • Healthcare • Medical - Devices • US • USD

SharesGrow Score
27/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — XENT

Intersect ENT, Inc. (XENT) and trades at $28.24. The 52-week range is 28.23-28.25.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -5.9, Earnings Per Share (EPS) of $-4.80, annual revenue of $106.75M.

The stock has a beta of 1.53, operates in the Healthcare sector.

Trading Data
Current Price$28.24
52-Week Range28.23-28.25
Avg Volume (30D)438.7K
Beta (1Y)1.53
Company
IPO Date2014-07-24
Employees433
CEOThomas West
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS46071F1030
CUSIP46071F103
Income (Latest Year)
Revenue$106.75M
Gross Profit$76.74M
EBITDA$-150.08M
Operating Income$-154.89M
Net Income$-159.64M
EPS$-4.80
EPS Diluted$-4.80
Shares Outstanding$33.27M
Balance Sheet (Latest Year)
Total Assets$146.87M
Current Assets$106M
Cash & ST Investments$61.02M
Total Liabilities$215.94M
Total Debt$142.06M
Net Debt$103.66M
Total Equity$-69.07M
Debt / Equity-2.06
Valuation Ratios
P/E Ratio-5.9
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message